Pain Management
YM Biosciences reports phase 2b interim trial review of AeroLEF indicates study to continue
Published in Medical Devices and Surgical Technology Week, November 5th, 2006
The data indicated that AeroLEF provided benefit compared to placebo, however the difference between the treatment arm and placebo arm had not yet achieved the significance level predefined in the study protocol and, therefore, the study will continue as planned to enroll the original target of 99 randomized patients.
"This preliminary review indicates...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Angiology
Aortic arch aneurysms are treated with combined surgical and endovascular techniques - Cancer Therapy
Sentinel lymph node biopsy technique using I-125-methylene blue is developed - Cardiology
Intramyocardial catheter delivery systems are compared in healthy and infarcted pigs - Medical Devices
Holmium laser enucleation is the better treatment for large prostates - Otorhinolaryngology
Pediatric cholesteatomas are adequately treated with canal wall up mastoidectomy - Biomedical Engineering
New biomedical engineering research reported from University of Newcastle, Center for Health Services Research - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
